Theravance Biopharma
TBPH
#6775
Rank
A$0.76 B
Marketcap
Country
$15.24
Share price
2.20%
Change (1 day)
9.11%
Change (1 year)

Theravance Biopharma (TBPH) - Total debt

Total debt on the balance sheet as of December 2024 : A$77.86 Million

According to Theravance Biopharma 's latest financial reports the company's total debt is A$77.86 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Theravance Biopharma - Total debt on balance sheet (from 2016 to 2024)

Total debt by year

Year Total debt Change
2024-12-31A$80.09 M11.01%
2023-12-31A$72.15 M-5.86%
2022-12-31A$76.64 M-91.7%
2021-12-31A$0.92 B5.01%
2020-12-31A$0.87 B20.61%
2019-12-31A$0.72 B13.06%
2018-12-31A$0.64 B125.04%
2017-12-31A$0.28 B-7.23%
2016-12-31A$0.30 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
A$1.34 B 1,624.81%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.84 M-86.08%๐Ÿ‡บ๐Ÿ‡ธ USA
A$4.98 M-93.60%๐Ÿ‡บ๐Ÿ‡ธ USA
A$7.73 B 9,829.75%๐Ÿ‡บ๐Ÿ‡ธ USA